Pharmacoeconomic considerations in the treatment of psoriatic arthritis

Rheumatology (Oxford). 2006 Jul;45(7):790-1. doi: 10.1093/rheumatology/kel153. Epub 2006 May 16.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / economics*
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Arthritis, Psoriatic / drug therapy*
  • Arthritis, Psoriatic / economics*
  • Cost-Benefit Analysis
  • Drug Costs
  • Humans
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Tumor Necrosis Factor-alpha